Homepage > Company > Media > Pharma News > 2017 > Sanofi to pay $19.8 million over claims of drug overcharges: U.S.

Sanofi to pay $19.8 million over claims of drug overcharges: U.S.

Sanofi SA (SASY.PA)'s Sanofi-Pasteur unit has agreed to pay $19.8 million to resolve claims that it overcharged the U.S. Department of Veterans Affairs for medications between 2002 and 2011, U.S. Justice officials said on Monday.

Sanofi-Pasteur, the company's vaccine division, had told the Veterans Affairs (VA) Department in 2012 that it had made an accounting error in overcharging for certain drugs, the Justice Department said in a statement.

In an emailed statement, a Sanofi spokeswoman said the company "cooperated fully and negotiated in good faith with the government."

(Reporting by Joel Schectman and Susan Heavey; Editing by James Dalgleish)

Mon Apr 3, 2017

Source: http://www.reuters.com/

Read also

FDA warns vs fake versions of popular medicines

MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...

Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

EMA to review CTIS transparency rules

Public consultation seeks the best methods for balancing transparency with confidentiality in the EU Clinical Trials Information System, says the European Medicines Agency. ...